Ac immune to present at the b. riley annual neuro & ophthalmology virtual investor conference

Lausanne, switzerland, april 27, 2022 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor meetings during the b.riley annual neuro & ophthalmology virtual investor conference, taking place virtually on april 27-28, 2022.
ACIU Ratings Summary
ACIU Quant Ranking